napyradiomycin C2(103106-19-0)
- Name: napyradiomycin C2
- Synonyms:NapyradiomycinC 2
- Molecular Formula:C25H27 Cl3 O5
- Molecular Weight:0
- CAS Registry Number:103106-19-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.103106-19-0 7,18a-Methano-6,10-metheno-5H-cyclohexadeca[b]pyran-5,19-dione,3,4a,13-trichloro-2,3,4,4a,11,12,13,14,15,18-decahydro-9,20-dihydroxy-2,2,16-trimethyl-12-methylene-(9CI)
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
CAS No.103106-19-0 napyradiomycin C2
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.103106-19-0 Napyradiomycin C2
Assay:95% Appearance:Yellow Brown Powder Storage:Store at -20掳C Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 308361-01-5/Oxirane, phenyl-, polymer with oxirane, mono(dihydrogen phosphate),3,5,5-trimethylhexyl ether
- 63731-93-1/4-[γ-(Diethylamino)propylamino]-5,6-dimethyl-2-pyrimidinamine
- 3571-36-6/[4-[[4-(diethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]diethylammonium chloride
- 40359-00-0/2,2-Dimethyl-2,3,4,5-tetrahydro-1,5-benzothiazepine
- 6255-32-9/1-[(4-nitrophenyl)acetyl]-2-{[4-(trifluoromethyl)benzyl]sulfanyl}-4,5-dihydro-1H-imidazole
- 84282-10-0/2'-(2,4-dichlorobenzoyl)-1-naphthohydrazide
- 155271-73-1/1,3-diethyl-7-methyl-8-{(E)-2-[3-(trifluoromethoxy)phenyl]ethenyl}-3,7-dihydro-1H-purine-2,6-dione
- 93151-77-0/butyl N-butyl-N-phenylcarbamimidate
- 125412-71-7/6-(1-hydroxyethyl)-2-(5-chloro-2-oxobenzoxazolin-3-yl)-1-methyl-1-carbapen-2-em-3-carboxylic acid
- 143168-92-7/3,5-Pyridinedicarboxylicacid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-,3-(4,4-diphenyl-1-piperidinyl)propyl methyl ester, monohydrochloride, (4S)-(9CI)
- 6633-63-2/N-hexadecylaniline
- 36676-05-8/9,10-Secoergostane
- 7787-37-3/Barium molybdate
- 33369-44-7/2-[5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrol-2-yl]propanoic acid
- 33448-78-1/thio-
- 130622-31-0/benzyl alcohol xylopyranosyl-(1-6)-glucopyranoside
- 28846-38-0/methyl hydrogen sulfate - 9-(2,2-dimethylhydrazinyl)acridine (1:1)
- 24342-44-7/α-(Diethylhydrazono)-4'-nitroacetophenone
- 6118-42-9/4-chloro-N-(4-sulfamoylbenzyl)benzamide
- 103106-19-0/napyradiomycin C2
- 2779-58-0/2-[2-(1,1-dioxido-1,4-thiazepan-4-yl)ethyl]guanidine sulfate (1:1)
- 152520-56-4/Nebivolol hydrochloride
- 65934-95-4/Fenitropan
- 97021-75-5/(4-hydroxy-3,5-dipropylphenyl)-N,N-dimethylmethanaminium chloride
- 40283-62-3/Thiosulfuric acid hydrogen S-[2-[(2-cycloheptylethyl)amino]-2-iminoethyl] ester
- 76971-29-4/Delcoridine
- 7511-87-7/3-(3-chlorophenyl)-2-(4-chlorophenyl)prop-2-enoic acid
- 37443-67-7/(E)-dec-2-enedioic acid
- 6965-80-6/4-methyl-2-(morpholin-4-ylmethyl)-3-oxo-3,4-dihydroquinazolin-3-ium
- 3722-12-1/[2-(4-nitrophenyl)hydrazinylidene]propanedinitrile